Perrigo Company plc (PRGO) Company Profile & Statistics

Perrigo Company plc
PRGO
(NYSE)
Closed
26.80
-0.13 (-0.48%)
in:usd•As of: Nov 15, 2024 15:59 UTC -5
Pre Market:0+0.00 (0.00%)
Open
26.96
High
27.35
Low
26.56

About Perrigo Company plc

CEO

Patrick Lockwood Taylor

Headquarters

the sharp building, hogan place

dublin, l2 d02, ireland

Auditor

Ernst & Young LLP

Employees

9,140

Share Holders

4,117

Website

www.perrigo.com

Industry

pharmaceuticals major

Sector

health technology

Company Overview

Perrigo Co. plc, with a diversified revenue stream, sells infant formulas for the store brand market, generic extended topical prescription (Rx) products and specialty pharmaceutical drugs. It's focusing on self-care products as part of its transformation into a self-care company from a healthcare company. The company divested its Rx segment to Altaris Capital Partners. The company completed its transformation to a consumer self-care company by reconfiguring the portfolio through the divestiture of RX business. Currently, the company has 2 reporting segments. Consumer Self Care Americas (CSCA): The segment comprises the U.S., Mexico and Canada CHC business, including OTC, contract manufacturing, infant formula and animal health categories. Consumer Self Care International?(CSCI): The segment comprises the branded consumer healthcare (BCH) segment mainly in Europe and the company's consumer-focused businesses in the UK and Australia. This segment includes UK liquids licensed products business.

Perrigo Company plc Statistics

Valuation Measures

Market Capitalization ²	3.66B
Enterprise Value	7.17B
Enterprise Value/EBITDA (ttm)	23.38
Price to Earnings Ratio (ttm)	10.77
Price to Book (mrq)	0.80
Price to Sales (ttm)	0.83
Price to Cash (ytd)	5.09

Profitability

Gross Margin (ttm)	35.91%
Operating Margin (ttm)	7.80%
Profit Margin (ttm)	-2.88%
Return on Equity (ttm)	7.38%
Return on Invested Capital (ttm)	-1.40%
Return on Assets (ttm)	3.18%

Income Statement

Revenue (ttm)	4.43B
Revenue Per Share (ttm)	32.46
Gross Profit (ttm)	1.59B
EBITDA (ttm)³	306.70M
Net Income Avi to Common (ttm)	-124.50M
Diluted EPS (ttm)	-1.17

Share Statistics

Beta (5Y Monthly)	0.48
52-Week Change	-8.47%
S&P500 52-Week Change	29.10%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	136.42M
Dividend Yield	4.12%
Float ⁴	135.47M
% Held by Insiders	0.70%
% Held by Institutions	95.91%

Balance Sheet

Total Cash (mrq)	542.80M
Total Cash Per Share (mrq)	3.98
Total Debt (mrq)	4.06B
Total Debt/Equity (mrq)	89.27%
Current Ratio (mrq)	1.99%
Quick Ratio (mrq)	1.77%
Book Value Per Share (mrq)	33.32

Cash Flow

Operating Cash Flow Per Share (ytd)	0.06
Free Cash Flow (ytd)	-45.40M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Perrigo Company plc

Trade With A Regulated Broker